These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1033 related items for PubMed ID: 20643629
1. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. Mortimer AM, Singh P, Shepherd CJ, Puthiryackal J. Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629 [Abstract] [Full Text] [Related]
2. Clozapine use in a forensic population in a New South Wales prison hospital. Martin A, O'Driscoll C, Samuels A. Aust N Z J Psychiatry; 2008 Feb; 42(2):141-6. PubMed ID: 18197509 [Abstract] [Full Text] [Related]
3. Clinical effects of a randomized switch of patients from clozaril to generic clozapine. Kluznik JC, Walbek NH, Farnsworth MG, Melstrom K. J Clin Psychiatry; 2001 Feb; 62 Suppl 5():14-7; discussion 23-4. PubMed ID: 11305843 [Abstract] [Full Text] [Related]
4. Effectiveness of clozapine use in delaying hospitalization in routine clinical practice: a 2 year observational study. Nyakyoma K, Morriss R. Psychopharmacol Bull; 2010 Feb; 43(2):67-81. PubMed ID: 21052043 [Abstract] [Full Text] [Related]
5. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing]. Mercier C, Bret P, Bret MC, Queuille E. Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368 [Abstract] [Full Text] [Related]
6. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia. Semiz UB, Cetin M, Basoglu C, Ebrinc S, Uzun O, Herken H, Balibey H, Algul A, Ates A. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug 15; 31(6):1330-6. PubMed ID: 17618026 [Abstract] [Full Text] [Related]
7. The effects of clozapine on aggression and substance abuse in schizophrenic patients. Volavka J. J Clin Psychiatry; 1999 Aug 15; 60 Suppl 12():43-6. PubMed ID: 10372611 [Abstract] [Full Text] [Related]
8. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand. Wheeler AJ. Ann Pharmacother; 2008 Jun 15; 42(6):852-60. PubMed ID: 18477732 [Abstract] [Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM, Leucht S, Carpenter D, Docherty JP, Expert Consensus Panel for Optimizing Pharmacologic Treatment of Psychotic Disorders. J Clin Psychiatry; 2003 Jun 15; 64 Suppl 12():5-19. PubMed ID: 14640142 [Abstract] [Full Text] [Related]
11. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia. Kelly DL, Feldman S, Boggs DL, Gale E, Conley RR. Compr Psychiatry; 2010 Jun 15; 51(3):298-302. PubMed ID: 20399340 [Abstract] [Full Text] [Related]
12. Reason for clozapine cessation. Pai NB, Vella SC. Acta Psychiatr Scand; 2012 Jan 15; 125(1):39-44. PubMed ID: 22017729 [Abstract] [Full Text] [Related]
13. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia. Flynn SW, MacEwan GW, Altman S, Kopala LC, Fredrikson DH, Smith GN, Honer WG. Pharmacopsychiatry; 1998 Jan 15; 31(1):25-9. PubMed ID: 9524981 [Abstract] [Full Text] [Related]
14. The combined use of risperidone long-acting injection and clozapine in patients with schizophrenia non-adherent to clozapine: a case series. Se Hyun Kim, Dong Chung Jung, Yong Min Ahn, Yong Sik Kim. J Psychopharmacol; 2010 Jul 15; 24(7):981-6. PubMed ID: 19942641 [Abstract] [Full Text] [Related]
15. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team. Preliminary results. Agius M, Shah S, Ramkisson R, Murphy S, Zaman R. Psychiatr Danub; 2007 Jun 15; 19(1-2):10-9. PubMed ID: 17603411 [Abstract] [Full Text] [Related]
16. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. Schizophr Bull; 2006 Oct 15; 32(4):715-23. PubMed ID: 16540702 [Abstract] [Full Text] [Related]
17. Clozapine maintenance therapy in schizophrenia. Gaszner P, Makkos Z. Prog Neuropsychopharmacol Biol Psychiatry; 2004 May 15; 28(3):465-9. PubMed ID: 15093952 [Abstract] [Full Text] [Related]
18. Using antipsychotic agents in older patients. Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. J Clin Psychiatry; 2004 May 15; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733 [Abstract] [Full Text] [Related]
19. Predictors of clozapine discontinuation in patients with schizophrenia. Krivoy A, Malka L, Fischel T, Weizman A, Valevski A. Int Clin Psychopharmacol; 2011 Nov 15; 26(6):311-5. PubMed ID: 21849905 [Abstract] [Full Text] [Related]
20. Early use of clozapine for poorly responding first-episode psychosis. Agid O, Remington G, Kapur S, Arenovich T, Zipursky RB. J Clin Psychopharmacol; 2007 Aug 15; 27(4):369-73. PubMed ID: 17632221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]